EndoGastric Solutions touts more MAC reimbursement wins for Esophyx device

EndoGastric Solutions said today that new Medicare Administrative Contractors Noridian Health Care Solutions and National Government Services have been granted reimbursement access for the transoral incisionless fundoplication procedure using its Esophyx device. The Redmond, Wash.-based company’s TIF procedure is designed to prevent stomach acids refluxing back into the esophagus by reconstructing the gastroesophageal valve. Noridian, which provides coverage for more than 10.7 million Medicare beneficiaries in 13 states, made the reimbursement decision effective October 27, while NGS, which covers approximately 10.1 million beneficiaries in 10 states, will make its decision effective December 1. “The need exists for safe, dependable treatment options to address reflux beyond invasive surgical operations and proton pump inhibitor dependence. The TIF 2.0 procedure provides a well-tested and proven therapeutic alternative to patients seeking lasting relief,” gastroenterologist Dr. Kenneth Chang of UC Irvine Health said in a prepared statement. “The robust body of clinical evidence which supports the TIF 2.0 procedure continues to demonstrate durable, positive outcomes for patients experiencing troublesome GERD symptoms. Now, patients who wish to avoid or discontinue PPI use and want a less invasive procedure than traditional surgery has access to sustained symptom relief with the TIF 2.0 alternative,” Dr. Kevin Reavis of the Oregon Clinic said in a ...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Otolaryngology Ear, Nose & Throat endogastricsolutions Source Type: news